Table 2 Outcomes in HSV and non-HSV patients
|  |  | All patients (n = 153) | Without HSV reactivation (n = 113) | HSV reactivation (n = 40) | p-value |
|---|---|---|---|---|---|
Length of stay ICU | Median (IQR) | 11.5 [7; 21.5] | 9 [6; 15] | 23 [17; 40] |  < 0.001 |
Death in ICU | Number (%) | 57 (37.3) | 36 (31.9) | 21 (52.5) | 0.024 |
Death at day 60 | Number (%) | 61 (39.9) | 38 (33.6) | 23 (57.5) | 0.014 |
HAP/VAP | Number (%) | 67 (43.8) | 34 (30.1) | 33 (82.5) |  < 0.001 |
ICU-BSI | Number (%) | 38 (24.8) | 20 (17.7) | 18 (45) | 0.001 |
IMV/ECMO | Number (%) | 89 (58.2) | 54 (47.8) | 35 (87.5) |  < 0.001 |